SCHEMBL3054403

SCHEMBL3054403

COc1ccc(S(=O)(=O)Oc2ccc(-c3cc4cc(CN5CCCCC5)ccc4n3C(=O)OC(C)(C)C)c3c2CNC3=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 5/20 0.36
BDKRB1 P46663 1/20 0.35
ATR Q13535 1/20 0.35
ATRIP Q8WXE1 1/20 0.35
MMP1 P03956 2/20 0.34
MMP9 P14780 2/20 0.34
MMP13 P45452 2/20 0.34
ADAM17 P78536 2/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
OXTR P30559 1/20 0.33
AVPR1A P37288 1/20 0.33
AVPR1B P47901 1/20 0.33
CNR2 P34972 1/20 0.32
CHEK1 O14757 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PTGS2 P35354 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3045896 0.93 MEN1 (0.34) NR1H2CHEK1KMT2ASMN1; SMN2
SCHEMBL3034029 0.93 NR1H2 (0.36) NR1H2BDKRB1ATRATRIP
SCHEMBL3042182 0.93 NR1H2 (0.40) NR1H2SMN1; SMN2
SCHEMBL3047451 0.93 NR1H2 (0.40) NR1H2ATRATRIPPOLBCNR2
SCHEMBL5046849 0.93 P2RX7 (0.35) NR1H2ATRATRIPMMP1MMP9
SCHEMBL3044012 0.93 NR1H2 (0.37) NR1H2BDKRB1LMNASMN1; SMN2PTGS2
SCHEMBL3040414 0.93 NR1H2 (0.34) NR1H2BDKRB1
SCHEMBL3046531 0.93 SMN1; SMN2 (0.35) NR1H2CHEK1SMN1; SMN2
SCHEMBL3039560 0.93 NR1H2 (0.40) NR1H2
SCHEMBL3048398 0.92 NR1H2 (0.36) NR1H2ATRATRIPOXTRAVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 NR1H2 21/4885BDKRB1 2607/4885ATR 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.